Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
Clinical trial NCT03652428 · RECRUITING
Trial details
- NCT number
- NCT03652428
- Sponsor
- University of Maryland, Baltimore
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-02
- Primary completion
- 2026-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.